Vensana Capital I GP, LLC - 09 Feb 2026 SCHEDULE 13D Report for SpyGlass Pharma, Inc. Common Stock, par value $0.00001 per share

Filing Manager
Vensana Capital I GP, LLC
Reporting Manager
Kirk Nielsen
Security
SpyGlass Pharma, Inc. Common Stock, par value $0.00001 per share
Shares outstanding
33,455,970 shares
Disclosed Ownership
3,312,141 shares
Ownership
9.9%
Form type
SCHEDULE 13D
Filing time
10 Feb 2026, 18:29:55 UTC
Date of event
09 Feb 2026
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Vensana Capital I GP, LLC 9.9% 3,310,619 0 3,310,619 /s/ Steven Schwen Steven Schwen, Chief Financial Officer 0001854073
Vensana Capital I, L.P. 9.9% 3,310,619 0 3,310,619 /s/ Steven Schwen Steven Schwen, Chief Financial Officer of Vensana Capital I GP, LLC, the general partner of Vensana Capital I, L.P. 0001757539
Kirk Nielsen 9.9% 3,312,141 1,522 3,310,619 /s/ Steven Schwen Attorney-in-Fact* 0001523522
Peter Justin Klein 9.9% 3,310,619 0 3,310,619 /s/ Steven Schwen Attorney-in-Fact* 0001608710